Found: 10
Select item for more details and to access through your institution.
Enhanced anti-neuroblastoma activity of a fenretinide complexed form after intravenous administration.
- Published in:
- Journal of Pharmacy & Pharmacology, 2012, v. 64, n. 2, p. 228, doi. 10.1111/j.2042-7158.2011.01403.x
- By:
- Publication type:
- Article
Water-soluble derivatives of 4-oxo- N-(4-hydroxyphenyl) retinamide: synthesis and biological activity.
- Published in:
- Chemical Biology & Drug Design, 2016, v. 88, n. 4, p. 608, doi. 10.1111/cbdd.12781
- By:
- Publication type:
- Article
Role of retinoic acid receptor overexpression in sensitivity to fenretinide and tumorigenicity of human ovarian carcinoma cells.
- Published in:
- International Journal of Cancer, 1999, v. 81, n. 5, p. 829, doi. 10.1002/(SICI)1097-0215(19990531)81:5<829::AID-IJC26>3.0.CO;2-3
- By:
- Publication type:
- Article
AF1q: A Novel Mediator of Basal and 4-HPR-Induced Apoptosis in Ovarian Cancer Cells.
- Published in:
- PLoS ONE, 2012, v. 7, n. 6, p. 1, doi. 10.1371/journal.pone.0039968
- By:
- Publication type:
- Article
4-oxo-N-(4-hydroxyphenyl)retinamide: Two Independent Ways to Kill Cancer Cells.
- Published in:
- PLoS ONE, 2010, v. 5, n. 10, p. 1, doi. 10.1371/journal.pone.0013362
- By:
- Publication type:
- Article
PLAB induction in fenretinide-induced apoptosis of ovarian cancer cells occurs via a ROS-dependent mechanism involving ER stress and JNK activation.
- Published in:
- Carcinogenesis, 2009, v. 30, n. 5, p. 824, doi. 10.1093/carcin/bgp067
- By:
- Publication type:
- Article
Randomized trial of fenretinide (4-HPR) to prevent recurrences, new localizations and carcinomas in patients operated on for oral leukoplakia: Long-term results.
- Published in:
- International Journal of Cancer, 2005, v. 115, n. 4, p. 625, doi. 10.1002/ijc.20923
- By:
- Publication type:
- Article
Relationship among pharmacokinetics and pharmacodynamics of fenretinide and plasma retinol reduction in neuroblastoma patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 5, p. 993, doi. 10.1007/s00280-010-1370-5
- By:
- Publication type:
- Article
Pharmacokinetics of oral fenretinide in neuroblastoma patients: indications for optimal dose and dosing schedule also with respect to the active metabolite 4-oxo-fenretinide.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 4, p. 655, doi. 10.1007/s00280-007-0649-7
- By:
- Publication type:
- Article
Sodium 4-Carboxymethoxyimino-(4-HPR) a Novel Water-Soluble Derivative of 4-Oxo-4-HPR Endowed with In Vivo Anticancer Activity on Solid Tumors.
- Published in:
- Frontiers in Pharmacology, 2017, p. 1, doi. 10.3389/fphar.2017.00226
- By:
- Publication type:
- Article